Etid klinik pou Atak kè nan Kentucky
3 etid pou Atak kè ap chèche patisipan nan sit nan Kentucky.
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology Associates of Kentuckiana, PSC, Louisville
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Graves Gilbert Clinic, Bowling Green
- Baptist Health Lexington, Lexington
- The Research Group of Lexington LLC, Lexington
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Louisville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT06927739Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.